Patient info Open main menu

Zenapax – patient leaflet, side effects, dosage

Medicine status: No longer supplied Details

Medicine strength:
5 mg/ml
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Zenapax

Sources: Original PDF (ema.europa.eu)

Facts about Zenapax

Active substance Daclizumab
Strength 5 mg/ml
Pharmaceutical form Solution for infusion
How is it taken Intravenous
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L04 Immunosuppressants
      1. L04A Immunosuppressants
        1. L04AC Interleukin inhibitors
          1. L04AC01 daclizumab
Codes BNF 08020200

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.